ArticlePloS one2025

Analysis of adverse drug reactions in 507 cases of Tislelizumab: A real-world retrospective study based on data from Guangxi, China.

Shaohuan Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.